Monoclonal antibodies to murine CD40 define two distinct functional epitopes

European Journal of Immunology
A W HeathM Howard

Abstract

Two rat IgG2a antibodies which define distinct epitopes on murine CD40 have been generated. These antibodies specifically bind recombinant murine CD40 expressed on L cells, and the soluble extracellular domain of murine CD40 coated onto microtiter plates. Both antibodies bind B220+ but not B220 murine spleen cells, and immunoprecipitate a 45-kDa protein from the surface of purified murine splenic B cells. These antibodies exhibit separate functional properties, consistent with the notion that they define two distinct CD40 epitopes. One of the monoclonal antibodies (designated 1C10) directly induces a specific proliferative response from mature murine B cells, up-regulates several B cell surface antigens, and rescues immature B lymphoma cells from anti-IgM-induced growth arrest. The other monoclonal antibody (designated 4F11) exhibits none of these properties, but is capable of synergizing with suboptimal amounts of either anti-IgM antibodies or the 1C10 agonistic anti-CD40 antibody to produce an optimal proliferative response of purified small dense B cells. Furthermore, 4F11 antibody synergizes with suboptimal amounts of 1C10 antibody to rescue B lymphoma cells from anti-IgM-induced growth arrest. The 1C10 and 4F11 antibodies ...Continue Reading

References

Dec 1, 1992·The Journal of Experimental Medicine·M K SpriggsW C Fanslow
May 7, 1992·Nature·R J ArmitageC R Maliszewski
Jul 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·R J NoelleA Aruffo
Aug 1, 1989·European Journal of Immunology·A ValléJ Banchereau
Dec 21, 1989·Nature·Y J LiuI C MacLennan
Jun 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·E A Clark, J A Ledbetter
Jul 1, 1993·The Journal of Experimental Medicine·S SaelandJ Banchereau
Feb 11, 1993·Nature·J P DiSantoG de Saint Basile

❮ Previous
Next ❯

Citations

Dec 23, 1998·European Journal of Immunology·J R TumangH C Liou
Mar 6, 2003·Molecular Immunology·Lena StrömEva Severinson
Sep 17, 2013·Cellular & Molecular Immunology·Gisela M Vaitaitis, David H Wagner
Aug 1, 1997·Immunology and Cell Biology·M C KeoghR A Lake
Aug 29, 2002·Clinical and Experimental Immunology·S JollesA Ager
Mar 31, 1998·Scandinavian Journal of Immunology·K AxcronaT Leanderson
Jan 26, 2011·Proceedings of the National Academy of Sciences of the United States of America·Juliana IdoyagaRalph M Steinman
Aug 1, 1996·The Journal of Experimental Medicine·N SolvasonM C Howard
May 16, 1998·The Journal of Experimental Medicine·N SolvasonM Howard
Mar 17, 2004·The Journal of Experimental Medicine·Laura C BonifazRalph M Steinman
Mar 1, 2006·The Journal of Experimental Medicine·Christine TrumpfhellerRalph M Steinman
Mar 31, 2001·Cancer Biotherapy & Radiopharmaceuticals·S S MetkarJ J Nadkarni
Apr 8, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Xiao YangXueqing Yu
Feb 26, 1998·Immunological Reviews·H SongJ Cerny
Jan 23, 2003·Annals of the New York Academy of Sciences·Thomas C MitchellPhilippa Marrack
Feb 19, 2011·Journal of Leukocyte Biology·Jennifer CarlringAndrew W Heath
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·E D HawkinsP D Hodgkin
Aug 30, 2001·Proceedings of the National Academy of Sciences of the United States of America·R M KedlS Dow
Mar 14, 2002·Proceedings of the National Academy of Sciences of the United States of America·David H WagnerKathryn Haskins
Jun 23, 2009·Molecular Immunology·Trivikram DasuSubbarao Bondada
Dec 10, 2014·European Journal of Immunology·Henrike VeningaJoke M M den Haan
May 3, 2007·Immunology·Caterina Hatzifoti, Andrew W Heath
Nov 3, 2010·Alcoholism, Clinical and Experimental Research·Ji FanAnnette J Schlueter

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antigenic Modulation

Antigenic modulation occurs when an antibody cross-links antigens on a cell surface, causing the antigens to become internalized. This can lead to therapeutic failure of monoclonal antibodies as the expression of the antigen becomes decreased on target cells. Find the latest research on antigenic modulation here.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.